First Quadrant’s Immunogen Inc IMGN Stock Holding History

First Quadrant’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-30,738	Closed	-$105K	–	857
2020 Q1	$105K	Buy	+30,738	New	+$134K	0.02%	458

Other funds holding IMGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

First Quadrant's IMGN Position: Q2 2020 in Review

First Quadrant sold out of Immunogen Inc (IMGN) in Q2 2020, closing a stake of 30,738 shares — an estimated $105K sold.

First Quadrant first reported a position in IMGN in Q1 2020 and held it in 1 quarter. The position peaked at $105K in Q1 2020. 189 funds tracked by Wall St. Rank hold IMGN as of Q2 2020.

First Quadrant reported no remaining Immunogen Inc position as of Q2 2020 after selling out during the quarter.
First Quadrant sold 30,738 Immunogen Inc shares in Q2 2020, an estimated $105K.
First Quadrant first reported a position in Immunogen Inc in Q1 2020 and held it in 1 quarter.
First Quadrant's Immunogen Inc position peaked at $105K in Q1 2020.
189 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2020.

Based on First Quadrant's 13F filing for Q2 2020, filed 28 Jul 2020.